Ellevest, Inc. Biocryst Pharmaceuticals Inc Transaction History

Ellevest, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$7.94 - $11.84 $1,850 - $2,758	233 New	233 $1,000
Q2 2022 Jul 18, 2022	BUY	$7.89 - $17.88 $733 - $1,662	93 Added 3100.0%	96 $1,000
Q4 2021 Jan 24, 2022	SELL	$11.18 - $15.46 $614 - $850	-55 Reduced 94.83%	3 $0
Q3 2021 Oct 19, 2021	BUY	$14.21 - $17.65 $213 - $264	15 Added 34.88%	58 $1,000
Q2 2021 Jul 13, 2021	BUY	$9.5 - $17.24 $380 - $689	40 Added 1333.33%	43 $1,000
Q4 2020 Feb 04, 2021	SELL	$3.37 - $8.61 $94 - $241	-28 Reduced 90.32%	3 $0
Q3 2020 Oct 26, 2020	BUY	$3.43 - $5.53 $41 - $66	12 Added 63.16%	31 $0
Q2 2020 Jul 06, 2020	BUY	$1.9 - $5.61 $36 - $106	19 New	19 $0

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.